On September 19, 2023 Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, reported that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in the following upcoming investor and industry conferences (Press release, Precigen, SEP 19, 2023, View Source [SID1234635254]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2023
Fireside chat on Tuesday, September 26 at 4:55 PM ET
New York, NY

Cell & Gene Meeting on the Mesa
Company presentation on Wednesday, October 11, 2023 at 3:30 PM PT
Carlsbad, CA

Cantor AML Virtual Panel
Panel discussion on acute myeloid leukemia (AML) on Thursday, October 26, 2023 at 2:00 PM ET
Virtual

Participants may view details for these events through Precigen’s website in the Events & Presentations section at investors.precigen.com/events-presentations.